dc.contributor.author
Rakislova, Natalia
dc.contributor.author
Montironi, Carla
dc.contributor.author
Aldecoa Ansórregui, Iban
dc.contributor.author
Fernandez, Eva
dc.contributor.author
Bombí, Josep Antoni
dc.contributor.author
Jimeno, Mireya
dc.contributor.author
Balaguer Prunés, Francesc
dc.contributor.author
Pellisé Urquiza, Maria
dc.contributor.author
Castells Garangou, Antoni
dc.contributor.author
Cuatrecasas Freixas, Miriam
dc.date.issued
2017-04-11T16:30:42Z
dc.date.issued
2017-04-11T16:30:42Z
dc.date.issued
2017-01-14
dc.date.issued
2017-04-11T16:30:45Z
dc.identifier
https://hdl.handle.net/2445/109652
dc.description.abstract
Background Pathologic lymph node staging is becoming a deficient method in the demanding molecular era. Nevertheless, the use of more sensitive molecular analysis for nodal staging is hampered by its high costs and extensive time requirements. Our aim is to take a step forward in colon cancer (CC) lymph node (LN) pathology diagnosis by proposing a feasible and efficient molecular method in routine practice using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Results Molecular detection of tumor cytokeratin 19 (CK19) mRNA with RT-LAMP was performed in 3206 LNs from 188 CC patients using two methods: individual analysis of 1449 LNs from 102 patients (individual cohort), and pooled LN analysis of 1757 LNs from 86 patients (pooling cohort). A median of 13 LNs (IQR 10-18) per patient were harvested in the individual cohort, and 18 LNs (IQR 13-25) per patient in the pooling cohort (p ≤ 0.001). The median of molecular assays performed in the pooling cohort was 2 per patient (IQR 1-3), saving a median of 16 assays/patient. The number of molecular assays performed in the individual cohort was 13 (IQR 10-18), corresponding to the number of LNs to be analyzed. The sensitivity and specificity of the pooling method for LN involvement (assessed by hematoxylin and eosin) were 88.9% (95% CI 56.5-98.0) and 79.2% (95% CI 68.9-86.8), respectively; concordance, 80.2%; PPV, 33.3%; NPV, 98.4%. The individual method had 100% sensitivity (95% CI 72.2-100), 44.6% specificity (95% CI 34.8-54.7), 50% concordance, 16.4% PPV, and 100% NPV. The amount of tumor burden detected in all LNs of a case, or total tumor load (TTL) was similar in both cohorts (p = 0.228). Conclusions LN pooling makes it possible to analyze a high number of LNs from surgical colectomies with few molecular tests per patient. This approach enables a feasible means to integrate LN molecular analysis from CC specimens into pathology diagnosis and provides a more accurate LN pathological staging with potential prognostic implications.
dc.format
application/pdf
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s12967-016-1114-3
dc.relation
Journal of Translational Medicine, 2017, vol. 15, num. 14
dc.relation
https://doi.org/10.1186/s12967-016-1114-3
dc.rights
cc-by (c) Rakislova, Natalia et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Càncer colorectal
dc.subject
Nodes limfàtics
dc.subject
Diagnòstic molecular
dc.subject
Colorectal cancer
dc.subject
Molecular diagnosis
dc.title
Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion